Literature DB >> 23294570

IFPA Senior Award Lecture: Reproductive immunology in perspective--reprogramming at the maternal-fetal interface.

J S Hunt1, M G Petroff.   

Abstract

Involvement of the maternal and fetal immune systems in the events of pregnancy was generally overlooked by reproductive biologists until the mid-twentieth century when many landmark explorations were reported. Now, more than half a century later, it is well understood that with the initiation of pregnancy, immune cells in mammalian uteri are reprogrammed, losing their cytotoxic potential and providing an immunosuppressive environment suitable for harboring the genetically different fetus. We propose that it is the placenta that is mainly responsible for this conversion and maintenance throughout pregnancy. Studies in our laboratory indicate that trophoblast-derived soluble HLA-G has a subtle but well defined role in programming uterine placental macrophages, a potentially destructive immune cell population. Thus, placental HLA-G plays a critical role in assuring that the developing fetus emerges unscathed at parturition.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23294570      PMCID: PMC3700590          DOI: 10.1016/j.placenta.2012.12.005

Source DB:  PubMed          Journal:  Placenta        ISSN: 0143-4004            Impact factor:   3.481


  33 in total

1.  Immunogenicity of the soluble isoforms of HLA-G.

Authors:  J S Hunt; J L Pace; P J Morales; C Ober
Journal:  Mol Hum Reprod       Date:  2003-11       Impact factor: 4.025

2.  Secretion of pro-apoptotic intron 4-retaining soluble HLA-G1 by human villous trophoblast.

Authors:  Corinne Solier; Maryse Aguerre-Girr; Françoise Lenfant; Agnès Campan; Alain Berrebi; Vera Rebmann; Hans Grosse-Wilde; Philippe Le Bouteiller
Journal:  Eur J Immunol       Date:  2002-12       Impact factor: 5.532

Review 3.  Current topic: the role of macrophages in the uterine response to pregnancy.

Authors:  J S Hunt
Journal:  Placenta       Date:  1990 Nov-Dec       Impact factor: 3.481

4.  Soluble HLA-G circulates in maternal blood during pregnancy.

Authors:  J S Hunt; L Jadhav; W Chu; D E Geraghty; C Ober
Journal:  Am J Obstet Gynecol       Date:  2000-09       Impact factor: 8.661

5.  A class I antigen, HLA-G, expressed in human trophoblasts.

Authors:  S Kovats; E K Main; C Librach; M Stubblebine; S J Fisher; R DeMars
Journal:  Science       Date:  1990-04-13       Impact factor: 47.728

6.  A human major histocompatibility complex class I gene that encodes a protein with a shortened cytoplasmic segment.

Authors:  D E Geraghty; B H Koller; H T Orr
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

7.  Placental cell expression of HLA-G2 isoforms is limited to the invasive trophoblast phenotype.

Authors:  Pedro J Morales; Judith L Pace; Jeralyn Sue Platt; Teresa A Phillips; Kim Morgan; Asgi T Fazleabas; Joan S Hunt
Journal:  J Immunol       Date:  2003-12-01       Impact factor: 5.422

8.  Immunomodulatory molecules are released from the first trimester and term placenta via exosomes.

Authors:  S K Kshirsagar; S M Alam; S Jasti; H Hodes; T Nauser; M Gilliam; C Billstrand; J S Hunt; M G Petroff
Journal:  Placenta       Date:  2012-10-26       Impact factor: 3.481

9.  Progesterone inhibits inducible nitric oxide synthase gene expression and nitric oxide production in murine macrophages.

Authors:  L Miller; E W Alley; W J Murphy; S W Russell; J S Hunt
Journal:  J Leukoc Biol       Date:  1996-03       Impact factor: 4.962

Review 10.  Cytokine networks in the uteroplacental unit: macrophages as pivotal regulatory cells.

Authors:  J S Hunt
Journal:  J Reprod Immunol       Date:  1989-09       Impact factor: 4.054

View more
  1 in total

Review 1.  HLA-G Orchestrates the Early Interaction of Human Trophoblasts with the Maternal Niche.

Authors:  Silvia Gregori; Giada Amodio; Federica Quattrone; Paola Panina-Bordignon
Journal:  Front Immunol       Date:  2015-03-30       Impact factor: 7.561

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.